Product logins

Find logins to all Clarivate products below.


: Regulatory

Here you will find relevant articles and insight into all Clarivate related products and news.

Mainland China’s NRDL: The expensive yet priceless ticket to market access Mainland China’s NRDL: The expensive yet priceless ticket to market access
Blog June 8, 2021
Mainland China’s NRDL: The expensive yet priceless ticket to market access
Regulatory
Blog March 25, 2020
Do EMA and FDA review outcomes for new active substances (NASs) align?
Cortellis drug approval EMA
Blog November 18, 2019
Q&A: Five simple strategies to ensure regulatory compliance when globalizing your development program
Cortellis globalization Health Technology Assessment
Blog December 5, 2017
The impact of the changing regulatory environment on the approval of new medicines, 2007-2016
Approval CIRS Cortellis
Blog October 25, 2017
Accelerating – and maintaining – drug approvals in the U.S.
accelerated approval Advisory Committee Biologics
Blog May 11, 2017
The shifting regulatory landscape impacts the review of new medicines
Approval CIRS Cortellis
Blog April 27, 2017
Innovation comes with hefty price tag as biopharma R&D spend climbs
Cortellis Innovation Medical Devices and IVDs
Blog April 24, 2017
EU Parliament votes into law twin regulations for IVDs, medical devices
Cortellis Medical Devices and IVDs Regulatory

Regulatory

Mainland China’s NRDL: The expensive yet priceless ticket to market access Mainland China’s NRDL: The expensive yet priceless ticket to market access
Blog June 8, 2021
Mainland China’s NRDL: The expensive yet priceless ticket to market access
Blog March 25, 2020
Do EMA and FDA review outcomes for new active substances (NASs) align?
Blog November 18, 2019
Q&A: Five simple strategies to ensure regulatory compliance when globalizing your development program
Blog December 5, 2017
The impact of the changing regulatory environment on the approval of new medicines, 2007-2016
Blog October 25, 2017
Accelerating – and maintaining – drug approvals in the U.S.
Blog May 11, 2017
The shifting regulatory landscape impacts the review of new medicines
Blog April 27, 2017
Innovation comes with hefty price tag as biopharma R&D spend climbs
Blog April 24, 2017
EU Parliament votes into law twin regulations for IVDs, medical devices
Reprocessing endoscopes: what is the true cost? Reprocessing endoscopes: what is the true cost?
Blog March 16, 2017
Reprocessing endoscopes: what is the true cost?